Unichem Laboratories Limited (NSE:UNICHEMLAB)

Unichem Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	895.8	1,548	1,838	1,092	774.61
Short-Term Investments	-	-	-	-	2,260	-
Trading Asset Securities	-	-	13.4	15.36	376.28	2,364
Cash & Short-Term Investments	895.8	895.8	1,561	1,853	3,728	3,139
Cash Growth	-41.16%	-42.61%	-15.76%	-50.30%	18.76%	-51.75%
Accounts Receivable	-	7,788	6,423	5,886	4,954	2,503
Other Receivables	-	193.9	172.3	96.35	135.5	428.35
Receivables	-	7,983	6,596	5,983	5,090	2,931
Inventory	-	9,932	7,443	6,288	6,083	5,548
Prepaid Expenses	-	221.2	211.3	234.32	210.48	189.98
Other Current Assets	-	1,348	1,656	1,561	1,372	1,965
Total Current Assets	-	20,380	17,467	15,919	16,484	13,773
Property, Plant & Equipment	-	13,100	13,172	14,026	14,823	14,464
Long-Term Investments	-	0.2	0.2	1.61	2.85	1,556
Goodwill	-	15.5	15.5	15.45	15.45	15.45
Other Intangible Assets	-	187	563.6	-	-	-
Long-Term Deferred Tax Assets	-	257.8	67.8	101.13	43.55	139.54
Other Long-Term Assets	-	1,753	1,462	1,867	1,818	1,309
Total Assets	-	35,694	32,750	31,930	33,188	31,257
Accounts Payable	-	4,026	3,513	2,907	1,832	2,101
Accrued Expenses	-	1,749	1,825	699.37	555.94	523.02
Short-Term Debt	-	3,403	1,553	2,081	2,157	1,006
Current Portion of Long-Term Debt	-	288.7	256.6	256.63	256.63	-
Current Portion of Leases	-	46.1	42.1	51.6	42.18	41.58
Current Income Taxes Payable	-	43.4	22.1	4.91	20.95	32.61
Current Unearned Revenue	-	9.7	76.9	245.27	269.49	282.88
Other Current Liabilities	-	378.1	88.3	150.56	387.32	1,070
Total Current Liabilities	-	9,943	7,376	6,396	5,521	5,058
Long-Term Debt	-	608.1	382.2	636.49	890.11	-
Long-Term Leases	-	251.9	241.6	114.93	145.71	143.1
Long-Term Deferred Tax Liabilities	-	-	-	-	-	137.02
Other Long-Term Liabilities	-	269.9	280.5	294.95	317.72	290.11
Total Liabilities	-	11,188	8,367	7,577	7,004	5,689
Common Stock	-	140.8	140.8	140.81	140.81	140.81
Additional Paid-In Capital	-	13.3	13.3	13.3	13.3	13.3
Retained Earnings	-	24,121	23,640	23,975	25,061	25,012
Comprehensive Income & Other	-	230.6	588.5	223.87	969.19	402.42
Shareholders' Equity	24,506	24,506	24,383	24,353	26,184	25,568
Total Liabilities & Equity	-	35,694	32,750	31,930	33,188	31,257
Total Debt	4,598	4,598	2,475	3,140	3,492	1,191
Net Cash (Debt)	-3,702	-3,702	-914.3	-1,288	236.25	1,948
Net Cash Growth	-	-	-	-	-87.87%	-56.14%
Net Cash Per Share	-52.63	-52.42	-12.99	-18.29	3.35	27.67
Filing Date Shares Outstanding	70.27	70.41	70.41	70.41	70.41	70.41
Total Common Shares Outstanding	70.27	70.41	70.41	70.41	70.41	70.41
Working Capital	-	10,436	10,091	9,523	10,963	8,716
Book Value Per Share	348.07	348.07	346.32	345.90	371.90	363.16
Tangible Book Value	24,303	24,303	23,804	24,338	26,169	25,553
Tangible Book Value Per Share	345.19	345.19	338.10	345.68	371.68	362.94
Land	-	37.5	37.8	37.8	37.8	37.8
Buildings	-	5,499	5,108	5,101	3,872	3,417
Machinery	-	13,362	11,908	11,587	9,123	7,842
Construction In Progress	-	306.7	1,227	1,475	4,938	5,675

Source: S&P Global Market Intelligence. Standard template. Financial Sources.